-
Signature
-
/s/ Lindsey Cochran, by power of attorney
-
Stock symbol
-
NET
-
Transactions as of
-
Feb 18, 2022
-
Transactions value $
-
$0
-
Form type
-
4/A - Amendment
-
Date filed
-
2/24/2022, 05:05 AM
-
Date Of Original Report
-
Feb 23, 2022
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
NET |
Class A Common Stock |
Conversion of derivative security |
|
+22.2K |
|
|
22.2K |
Feb 18, 2022 |
By Irrevocable Trust |
F1, F2 |
transaction |
NET |
Class A Common Stock |
Other |
|
-22.2K |
-100% |
|
0 |
Feb 18, 2022 |
By Irrevocable Trust |
F1, F2, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
NET |
Class B Common Stock |
Conversion of derivative security |
$0 |
-22.2K |
-1.38% |
$0.00 |
1.59M |
Feb 18, 2022 |
Class A Common Stock |
22.2K |
|
By Irrevocable Trust |
F1, F2 |
transaction |
NET |
Class B Common Stock |
Conversion of derivative security |
$0 |
-27.8K |
-0.73% |
$0.00 |
3.77M |
Feb 22, 2022 |
Class A Common Stock |
27.8K |
|
By Revocable Trust |
F1, F4 |
transaction |
NET |
Class B Common Stock |
Conversion of derivative security |
$0 |
-5.56K |
-0.35% |
$0.00 |
1.59M |
Feb 22, 2022 |
Class A Common Stock |
5.56K |
|
By Irrevocable Trust |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
This amendment on Form 4 is filed to correct the indirect ownership in Rows 1 and 2 of Table I and Row 1 of Table II from The Sutherland/Zatlyn Revocable Trust dated November 17, 2016, for which the reporting person serves as co-trustee (the "Revocable Trust") to The Sutherland/Zatlyn Irrevocable Remainder Trust dated December 15, 2017, for which the reporting person serves as co-trustee (the "Irrevocable Trust"). In Column 9 of Rows 1, 2 and 3 of Table II, the amount of shares beneficially owned has been revised to reflect the change in Row 1 of Table II above. In addition, the last sentence of footnote 5 of the prior Form 4 should be revised as follows: The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (5) through (9) to this Form 4.